ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer

Published:2024-03 Issue: Volume:Volume 16 Page:127-139
ISSN:1179-1314
Container-title:Breast Cancer: Targets and Therapy
language:en
Short-container-title:BCTT

Author:

Rangel Nelson^ORCID,Sánchez Iris,Valbuena Duván,Rondón-Lagos Milena^ORCID

Publisher

Informa UK Limited

Reference56 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Breast cancer

3. A Three-Gene Model to Robustly Identify Breast Cancer Molecular Subtypes

4. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of Resistance to Systemic Therapy in Patients with Breast Cancer. Madame curie bioscience database. Available from: https://www.ncbi.nlm.nih.gov/books/NBK6306/. Accessed October 17, 2023.

5. Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP